Servier is a French pharmaceutical company, founded in 1954, and the first independent pharmaceutical group. Servier is present in 148 countries, with more than 21 200 employees, including close to 3000 in R&D.

Considering that chronic condition is debilitating and particularly complex to manage and most often poses a significant challenge for heart failure patients, which is why Servier embarked on this project to provide heart failure patients with an educational and monitoring tool, always in agreement with health care professionals, to manage their heart failure patients better.

For more information about Servier and heart failure disease, please go the website: